Adagio Medical, Inc.
Adagio Medical, Inc., is a privately held medical device company located in Laguna Hills, California. Co-founded in 2011 by Dr. James Cox, the inventor of “gold standard” Cox-Maze procedure, and Olav Bergheim, a serial entrepreneur, Adagio Medical is developing innovative ablation technologies for the treatment of cardiac arrhythmias including atrial fibrillation, atrial flutter, and ventricular tachycardia. Adagio’s unique portfolio is based on Ultra-Low Temperature Cryoablation (ULTC) and Pulsed-Field Cryoablation (PFCA) designed to produce durable, contiguous, transmural lesions anywhere in the heart.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Internationally (various countries)
About Us
A Leading Innovator in Treatment of Cardiac Arrhythmias
Adagio Medical was founded in 2011 on the vision of bringing the durability of surgical treatments of cardiac arrhythmias to patients undergoing minimally invasive cardiac ablations for atrial fibrillation, atrial flutter, and ventricular tachycardia. Since then, Adagio has pioneered a number of unique ablation technologies such as ultra-low temperature cryoablation (ULTC) and pulsed field cryoablation (PFCA), designed to produce durable, contiguous, transmural lesions anywhere in the heart. Discover Adagio’s “coolest” innovations in cardiac ablation technology, and deep dive into our technology portfolio, world-wide clinical studies and cutting-edge research.
Information for Patients
Our Mission
The Adagio Medical, Inc. mission is to be a leading innovator in the treatment of cardiac arrhythmias, committed to improving patient outcomes by developing catheter ablation technologies of uncompromising durability, versatility and safety.